Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,326 | -19,548 | -14,109 | -9,374 | -4,081 |
| Depreciation Amortization | 10 | 85 | 74 | 62 | 32 |
| Other Working Capital | 422 | -6,852 | -7,533 | -7,693 | -7,250 |
| Other Operating Activity | 647 | 1,892 | 1,375 | 892 | 324 |
| Operating Cash Flow | $-4,247 | $-24,423 | $-20,194 | $-16,113 | $-10,975 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -37 | -55 | -53 | -8 |
| Purchase Of Investment | N/A | -3,360 | -3,360 | N/A | N/A |
| Sale Of Investment | 1,231 | 2,129 | 1,035 | N/A | N/A |
| Other Investing Activity | 26 | 28 | 32 | 13 | -6 |
| Investing Cash Flow | $1,253 | $-1,240 | $-2,348 | $-40 | $-14 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 27,000 | 27,000 | 17,000 | 11,000 |
| Common Stock Issued | 3 | 146 | 6 | 6 | 6 |
| Other Financing Activity | 0 | -58 | -58 | 0 | 0 |
| Financing Cash Flow | $5,003 | $27,088 | $26,948 | $17,006 | $11,006 |
| Beginning Cash Position | 2,933 | 1,509 | 1,509 | 1,509 | 1,509 |
| End Cash Position | 4,942 | 2,933 | 5,916 | 2,362 | 1,526 |
| Net Cash Flow | $2,008 | $1,425 | $4,407 | $853 | $18 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,247 | -24,423 | -20,194 | -16,113 | -10,975 |
| Capital Expenditure | -5 | -37 | -55 | -53 | -8 |
| Free Cash Flow | -4,251 | -24,460 | -20,249 | -16,165 | -10,982 |